8-88186546-T-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_005941.5(MMP16):ā€‹c.334A>Cā€‹(p.Lys112Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000118 in 1,609,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000014 ( 0 hom., cov: 27)
Exomes š‘“: 0.000012 ( 0 hom. )

Consequence

MMP16
NM_005941.5 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.81
Variant links:
Genes affected
MMP16 (HGNC:7162): (matrix metallopeptidase 16) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The encoded protein activates MMP2 by cleavage. This gene was once referred to as MT-MMP2, but was renamed as MT-MMP3 or MMP16. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11534962).
BS2
High AC in GnomAdExome4 at 17 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MMP16NM_005941.5 linkuse as main transcriptc.334A>C p.Lys112Gln missense_variant 3/10 ENST00000286614.11 NP_005932.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MMP16ENST00000286614.11 linkuse as main transcriptc.334A>C p.Lys112Gln missense_variant 3/101 NM_005941.5 ENSP00000286614 P1P51512-1
MMP16ENST00000544227.5 linkuse as main transcriptn.334A>C non_coding_transcript_exon_variant 3/81
MMP16ENST00000522726.1 linkuse as main transcriptc.385A>C p.Lys129Gln missense_variant 4/54 ENSP00000429147
MMP16ENST00000520568.1 linkuse as main transcriptn.384A>C non_coding_transcript_exon_variant 3/32

Frequencies

GnomAD3 genomes
AF:
0.0000135
AC:
2
AN:
148114
Hom.:
0
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000140
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000637
AC:
16
AN:
251342
Hom.:
0
AF XY:
0.0000368
AC XY:
5
AN XY:
135836
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000116
AC:
17
AN:
1461472
Hom.:
0
Cov.:
33
AF XY:
0.00000825
AC XY:
6
AN XY:
727050
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000335
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000135
AC:
2
AN:
148114
Hom.:
0
Cov.:
27
AF XY:
0.00
AC XY:
0
AN XY:
71836
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000140
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000264
ExAC
AF:
0.0000659
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 20, 2021The c.334A>C (p.K112Q) alteration is located in exon 3 (coding exon 3) of the MMP16 gene. This alteration results from a A to C substitution at nucleotide position 334, causing the lysine (K) at amino acid position 112 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.18
T;.
Eigen
Benign
0.079
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.88
D;D
M_CAP
Benign
0.0084
T
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L;.
MutationTaster
Benign
0.97
N
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.8
N;D
REVEL
Benign
0.077
Sift
Benign
0.036
D;T
Sift4G
Benign
0.16
T;.
Polyphen
0.010
B;.
Vest4
0.32
MutPred
0.46
Loss of methylation at K112 (P = 0.0085);.;
MVP
0.48
MPC
0.97
ClinPred
0.16
T
GERP RS
5.7
Varity_R
0.25
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs745987268; hg19: chr8-89198775; API